Cardlytics Proceeds Revenue Tightening In The Middle Of Deteriorating Economics (NASDAQ: CDLX)

.Financial writer highly recommends offering Cardlytics, Inc. due to decreasing device business economics, earnings problems, and damaging monetary trends. Click on for this CDLX improve.